Washington, DC 20006-5349
HELPLINE
The pre-application period for the Peer Reviewed Cancer Research Program (PRCRP) submission is now open and accepting Letters of Intent (LOIs). To help researchers succeed…
On Thursday, March 23, at 9 AM EDT, the Mesothelioma Applied Research Foundation will be host a new episode of its Meet the Mesothelioma Experts…
UPDATE: On March 10, 2023, Merck announced through a press release that its Phase 3 study met its primary endpoint of overall survival which was…
The Mesothelioma Applied Research Foundation (Meso Foundation) is a non-profit organization that provides support, education, and advocacy for individuals and families affected by mesothelioma, a…
Mesothelioma in and of itself is a misunderstood diagnosis. As a cancer that affects roughly 3,000 Americans per year, it is often mistakenly thought of…
Last week, the Polaris Group announced positive results of its Phase 2/3 clinical trial evaluating the effectiveness of an arginine degrading enzyme agent called ADI-PEG 20.…
The Mesothelioma Applied Research Foundation is proud to announce the recipients of its most recent round of new mesothelioma research funding. Through a rigorous review…
Today, the Mesothelioma Applied Research Foundation announced its 2022 mesothelioma award recipients for its Pioneer Award, the Klaus Brauch Above and Beyond Award, and the…
For over 18 years, the International Symposium on Malignant Mesothelioma has been the go-to place for mesothelioma patients and their families to find community and…
A new study just published in the journal Science challenged our collective hope that natural infection by Omicron would convey a degree of immunity that…
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
